10
IRUS TotalDownloads
Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study
File | Description | Size | Format | |
---|---|---|---|---|
![]() | Published version | 1.09 MB | Adobe PDF | View/Open |
Title: | Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study |
Authors: | Birgand, G Mutters, NT Ahmad, R Tacconelli, E Lucet, J-C Holmes, A |
Item Type: | Journal Article |
Abstract: | Background Using case-vignettes, we assessed the perception of European infection control (IC) specialists regarding the individual and collective risk associated with antimicrobial resistance (AMR) among inpatients. Methods In this study, sixteen case-vignettes were developed to simulate hospitalised patient scenarios in the field of AMR and IC. A total of 245 IC specialists working in different hospitals from 15 European countries were contacted, among which 149 agreed to participate in the study. Using an online database, each participant scored five randomly-assigned case-vignettes, regarding the perceived risk associated with six different multidrug resistant organisms (MDRO). The intra-class correlation coefficient (ICC), varying from 0 (poor) to 1 (perfect), was used to assess the agreement for the risk on a 7-point Likert scale. High risk and low/neutral risk scorers were compared regarding their national, organisational and individual characteristics. Results Between January and May 2017, 149 participants scored 655 case-vignettes. The perceptions of the individual (clinical outcome) and collective (spread) risks were consistently lower than other MDRO for extended spectrum beta-lactamase producing Enterobacteriaceae cases and higher for carbapenemase producing Enterobacteriaceae (CPE) cases. Regarding CPE cases, answers were influenced more by the resistance pattern (93%) than for other MDRO. The risk associated with vancomycin resistant Enterococci cases was considered higher for the collective impact than for the individual outcome (63% vs 40%). The intra-country agreement regarding the individual risk was globally poor varying from 0.00 (ICC: 0–0.25) to 0.51 (0.18–0.85). The overall agreement across countries was poor at 0.20 (0.07–0.33). IC specialists working in hospitals preserved from MDROs perceived a higher individual (local, p = 0.01; national, p < 0.01) and collective risk (local and national p < 0.01) than those frequently exposed to bacteraemia. Conversely, IC specialists working in hospitals with a high MDRO clinical burden had a decreased risk perception. Conclusions The perception of the risk associated with AMR varied greatly across IC specialists and countries, relying on contextual factors including the epidemiology. IC specialists working in high prevalence areas may underestimate both the individual and collective risks, and might further negatively promote the MDRO spread. These finding highlight the need to shape local and national control strategies according to risk perceptions and contextual factors. |
Issue Date: | 14-Feb-2020 |
Date of Acceptance: | 6-Feb-2020 |
URI: | http://hdl.handle.net/10044/1/77673 |
DOI: | 10.1186/s13756-020-0695-z |
ISSN: | 2047-2994 |
Publisher: | BioMed Central |
Journal / Book Title: | Antimicrobial Resistance and Infection Control |
Volume: | 9 |
Copyright Statement: | © The Author(s). 2020. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Sponsor/Funder: | ESRC National Institute for Health Research National Institute for Health Research |
Funder's Grant Number: | HPRU-2012-10047 HPRU-2012-10047 |
Keywords: | Science & Technology Life Sciences & Biomedicine Public, Environmental & Occupational Health Infectious Diseases Microbiology Pharmacology & Pharmacy Europe Infection prevention and control Antimicrobial resistance Risk perception Carbapenemase-producing Enterobacteriaceae Meticillin-resistant Staphylococcus aureus Carbapenemase-producing Pseudomonas aeruginosa Carbapenemase-producing Acinetobacter baumannii Vancomycin-resistant Enterococci GUIDELINES PHYSICIANS MORTALITY Antimicrobial resistance Carbapenemase-producing Acinetobacter baumannii Carbapenemase-producing Enterobacteriaceae Carbapenemase-producing Pseudomonas aeruginosa Europe Infection prevention and control Meticillin-resistant Staphylococcus aureus Risk perception Vancomycin-resistant Enterococci Percept-R Study Group 0605 Microbiology 1103 Clinical Sciences 1108 Medical Microbiology |
Publication Status: | Published |
Article Number: | ARTN 33 |
Appears in Collections: | Department of Infectious Diseases |